ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie, Caraway Research Targets TMEM17
ScripAbCellera and Lilly’s Coronavirus Antibody Enters Phase I Trials Eli Lilly & Co. has begun Phase I trials of anti-COVID-19 antibody candidate which could be used both as a treatment and a means of p
ScripLate-breaking science sessions at this year’s American Heart Association meeting taking place from 16-18 November in Philadelphia, PA, will include some closely watched late-stage studies, including f
ScripTetraphase Pharmaceuticals Inc. took the first step toward following fellow antibiotic developer Achaogen Inc. 's troubled path, deciding recently to reorganize its business so that it can focus ent